Empresa NuGenerex Immuno-Oncology, Inc.
Acciones
NUGX
US67053X1028
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 6
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 01/01/17 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | - |
Eric von Hofe
PSD | President | 66 | - |
Jason Terrell
CTO | Chief Tech/Sci/R&D Officer | 43 | - |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 18/01/17 |
Director/Board Member | 54 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Marvin Hausman
BRD | Director/Board Member | 82 | - |
Brian T. McGee
BRD | Director/Board Member | 63 | - |
Carol A. Nacy
BRD | Director/Board Member | 76 | - |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 18/01/17 |
Craig Eagle
BRD | Director/Board Member | 57 | - |
Joseph Moscato
CEO | Chief Executive Officer | 61 | 01/01/17 |
Director/Board Member | 54 | - | |
Thomas Leonard
BRD | Director/Board Member | 50 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 101 196 670 | 33 149 554 ( 32,76 %) | 0 | 32,76 % |
Información de la empresa
NuGenerex Immuno-Oncology, Inc.
10102 USA Today Way Suite 200
33025, Miramar
+(416) 364-2551
http://www.nugenerexio.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,96 % | 105 mil M | |
-1,43 % | 104 mil M | |
+4,40 % | 22,94 mil M | |
-12,15 % | 22,34 mil M | |
-4,36 % | 19,25 mil M | |
-39,98 % | 17,08 mil M | |
-10,04 % | 16,96 mil M | |
+6,79 % | 14,16 mil M | |
+38,61 % | 12,63 mil M |